ICAM1 and cutaneous mastocytosis: These results suggest a dual specificity of the LMP-420 molecule, which can act on two of the majors cytokines involved in CM pathogenesis [10], leading in vitro to a reduction of the PRBC cytoadhesion of P. falciparum populations binding to ICAM-1.